Drug Therapies Researched or Applied to Treat COVID-19
From early on during the COVID-19 pandemic, many potential drug therapies became and remain controversial. The various medications in this article may include both effective and ineffective treatments of the SARS-CoV-2 virus and the resulting COVID-19 disease state. The primary purpose is to categorize and summarize those treatments here.
How to Procure SARS-CoV-2/COVID-19 Prophylaxis and Treatments
Research Summaries
Hundreds of studies on dozens of drugs used during the COVID-19 pandemic are documented and summaried at www.c19study.com.
Antiseptic Mouth/Nose Wash
Antidepressants
While antidepressants may not seem like the most important class of repurposed drugs, COVID-19 is a unique disease, and it may not always be clear what biochemical influences might help some of those affected fight off the disease.
Antivirals
An antiviral agent is any agent that works as an antiviral, and may or may not otherwise be ordinarily recognized as a drug or have other medical uses.
See also zinc ionophores
Anti-Androgen Therapy
Blood Thinners/Anticoagulants
Since clotting is among the most damaging symptoms of COVID-19, numerous anticoagulants have been used by some doctors.
Fusion Inhibitor Peptides
Enfuvirtide
An in silico study showed that enfuvirtide can act as a potent SARS-CoV-2 fusion inhibitor.1)
Immune Modulators
Oxygen
Ventilators
Steroids
Corticosteroids
Other Mechanisms of Action
Public Health Measures
Vaccines
Many COVID-19 vaccines have been deployed with others in the development pipeline.
Vitamins, Minerals, and Nutraceuticals
Many vitamins, minerals, and nutraceutical supplements have been proposed, tested, or used in the treatment of SARS-CoV-2 and COVID-19.
Multidrug Treatment Protocols
Many medical doctors have shared the results of multidrug treatment protocols that they have used with patients in their practice.
| Protocol Name | # of patients treated | # of patients hospitalized | # of patients died | Case Fatality Rate |
|---|---|---|---|---|
| Dr. Syed Haider IVM + FLV2) | 4,000+ | 5 | 0 | 0 |
| Zelenko High Risk Patient Protocol 3) | 141 | 4 | 1 | 0.7% |
| Tyson Farid mild | 7,000 | 2 | 0 | 0 |
| Tyson Farid moderate4) | 413 | 7 | 3 | 0.7% |
| Italy Protocol | 66,000 | ? | 4 | 0.00606% |
| Chetty 8th Day Therapy 5) 6) | 4,000 | |||
| Demello 7) | 10,000+ | ?? | ?? | ?? |
Dr. Peter McCullough has also developed early outpatient treatment protocols, publishing his findings at the end of 2020 and beginning of 2021: https://pubmed.ncbi.nlm.nih.gov/33387997/ https://pubmed.ncbi.nlm.nih.gov/32771461/